Advertisement

ADVERTISEMENT

atopic dermatitis

News
Adults With and Without Atopic Dermatitis Choose Moisturizers for Personal Satisfaction
06/14/2022
According to a study, physicians should continue to educate patients with atopic dermatitis on the importance of using moisturizers to restore the skin barrier.
According to a study, physicians should continue to educate patients with atopic dermatitis on the importance of using moisturizers to restore the skin barrier.
According to a study, physicians...
06/14/2022
The Dermatologist
News
IL4RA and Food Allergy Association Is Mediated by Atopic Dermatitis in School-Aged Children
06/14/2022
According to a study, atopic dermatitis (AD) mediates the interleukin-4 receptor alpha chain gene variant and food allergy association in school-aged children.
According to a study, atopic dermatitis (AD) mediates the interleukin-4 receptor alpha chain gene variant and food allergy association in school-aged children.
According to a study, atopic...
06/14/2022
The Dermatologist
News
Parents and Children with AD Prioritize Different Aspects of Emollients
06/14/2022
A study found that children with eczema and their parents evaluate emollients based on different aspects and there is no universal type for each patient.
A study found that children with eczema and their parents evaluate emollients based on different aspects and there is no universal type for each patient.
A study found that children with...
06/14/2022
The Dermatologist
April Armstrong, MD, MPH, Dermatology Week 2022
Conference Coverage
Novel Topical PDE-4 Inhibitors For Plaque Psoriasis, Atopic Dermatitis, and Seborrheic Dermatitis
05/12/2022
Riya Gandhi, MA, Associate Editor
On the first day of Dermatology Week 2022, April Armstrong, MD, MPH, opened her session by noting, “There are common unmet needs in inflammatory skin diseases and that created opportunities for new well tolerated and effective topical...
On the first day of Dermatology Week 2022, April Armstrong, MD, MPH, opened her session by noting, “There are common unmet needs in inflammatory skin diseases and that created opportunities for new well tolerated and effective topical...
On the first day of Dermatology...
05/12/2022
The Dermatologist
News
Atopic Dermatitis Associated with Cardiovascular Disease
09/24/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Patients with atopic dermatitis (AD) and metabolic disorders are at risk for developing cardiovascular disease (CVD) and major cardiovascular events (MACE), according to a study published in Dermatology and Therapy. Researchers aimed to...
Patients with atopic dermatitis (AD) and metabolic disorders are at risk for developing cardiovascular disease (CVD) and major cardiovascular events (MACE), according to a study published in Dermatology and Therapy. Researchers aimed to...
Patients with atopic dermatitis...
09/24/2021
The Dermatologist
News
Increased Air Pollution Linked to AD and Chronic Inflammatory Skin Diseases
09/24/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
According to a study published in Clinical and Experimental Dermatology, particulate matter (PM) is associated with atopic dermatitis (AD) and chronic inflammatory skin diseases in South Korea. Researchers aimed to investigate the...
According to a study published in Clinical and Experimental Dermatology, particulate matter (PM) is associated with atopic dermatitis (AD) and chronic inflammatory skin diseases in South Korea. Researchers aimed to investigate the...
According to a study published...
09/24/2021
The Dermatologist
Covid
Risk for SARS-CoV-2 in Patients With Atopic Dermatitis Not Increased
09/24/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
SARS-CoV-2 infection rates and hospitalizations within 2 weeks of a SARS-CoV-2 test in patients with atopic dermatitis (AD) are not significantly increased from those without AD, according to a study published in British Journal of...
SARS-CoV-2 infection rates and hospitalizations within 2 weeks of a SARS-CoV-2 test in patients with atopic dermatitis (AD) are not significantly increased from those without AD, according to a study published in British Journal of...
SARS-CoV-2 infection rates and...
09/24/2021
The Dermatologist
Eczema Cream
Crisaborole Efficacious and Well Tolerated in Patients With Mild to Moderate AD
09/24/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Crisaborole is well tolerated and effective in patients with mild to moderate atopic dermatitis (AD) and other comorbidities, according to a recent study published in Allergy and Asthma Proceedings. Researchers performed a post hoc...
Crisaborole is well tolerated and effective in patients with mild to moderate atopic dermatitis (AD) and other comorbidities, according to a recent study published in Allergy and Asthma Proceedings. Researchers performed a post hoc...
Crisaborole is well tolerated...
09/24/2021
The Dermatologist
Severe Leg Eczema
Severe AD Linked to Mental Health Outcomes Across Childhood
09/24/2021

Lisa Kuhns, PhD

Lisa Kuhns, PhD
Severe atopic dermatitis (AD) is associated with symptoms of depression and internalizing behaviors across childhood and adolescence. Researchers examined the association between AD and internalizing behaviors and symptoms of depression...
Severe atopic dermatitis (AD) is associated with symptoms of depression and internalizing behaviors across childhood and adolescence. Researchers examined the association between AD and internalizing behaviors and symptoms of depression...
Severe atopic dermatitis (AD) is...
09/24/2021
The Dermatologist
News
New JAK Inhibitor Shows Efficacy, Safety in Phase 3 Trials for Atopic Dermatitis
06/01/2021
Lauren Mateja, Managing Editor
Upadacitinib, an oral Janus kinase (JAK) 1 inhibitor, was found to be safe and efficacious for the treatment of atopic dermatitis (AD) in two phase 3 clinical trials. The results of the trials were published in The Lancet. The Measure Up 1...
Upadacitinib, an oral Janus kinase (JAK) 1 inhibitor, was found to be safe and efficacious for the treatment of atopic dermatitis (AD) in two phase 3 clinical trials. The results of the trials were published in The Lancet. The Measure Up 1...
Upadacitinib, an oral Janus...
06/01/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use